Gynecologic pathology is a subspecialty of anatomic and clinical pathology that focuses on the study, diagnosis, and classification of diseases affecting the female reproductive system. This field encompasses the investigation of both benign and malignant conditions of the uterus, cervix, ovaries, fallopian tubes, vagina, vulva, and placenta.
Scope and Sub‑disciplines
- Histopathology: Microscopic examination of tissue specimens obtained from biopsies, surgical resections, or autopsies to identify structural abnormalities.
- Cytopathology: Evaluation of exfoliated or aspirated cells, most notably through the Papanicolaou (Pap) smear for cervical screening, as well as fine‑needle aspiration of ovarian masses.
- Molecular pathology: Application of DNA, RNA, and protein analysis (e.g., PCR, next‑generation sequencing, in‑situ hybridization) to detect genetic alterations, viral infections (e.g., human papillomavirus), and biomarkers relevant to prognosis and therapy.
- Immunohistochemistry (IHC): Use of antibody‑based staining to differentiate tumor types, assess hormone receptor status, and guide targeted treatments.
Common Pathologies Evaluated
- Cervical lesions: Cervical intraepithelial neoplasia (CIN), squamous cell carcinoma, adenocarcinoma, and HPV‑related changes.
- Uterine disorders: Endometrial hyperplasia, endometrial carcinoma, leiomyomas (fibroids), adenomyosis, and placental abnormalities.
- Ovarian conditions: Benign cystic lesions, borderline tumors, epithelial ovarian cancers (serous, mucinous, endometrioid, clear cell), germ cell tumors, and sex‑cord stromal tumors.
- Fallopian tube pathology: Tubal carcinoma, serous tubal intraepithelial carcinoma (STIC), and inflammatory diseases.
- Vaginal and vulvar diseases: Lichen sclerosus, vulvar intraepithelial neoplasia, and squamous cell carcinoma.
Diagnostic Techniques
- Gross examination: Macroscopic assessment of resected organs or lesions for size, shape, and consistency.
- Fixation and processing: Formalin fixation, paraffin embedding, and sectioning for microscopic slide preparation.
- Staining: Routine hematoxylin‑eosin (H&E) staining, special stains (e.g., PAS, Masson’s trichrome), and IHC panels.
- Molecular assays: Testing for BRCA1/2 mutations, mismatch repair deficiency, and other genomic alterations that influence management.
Clinical Relevance
Accurate gynecologic pathological diagnosis is essential for determining prognosis, selecting appropriate surgical or medical therapies, and guiding follow‑up strategies. For example, the identification of high‑risk HPV types in cervical cytology informs vaccination and screening policies, while molecular profiling of ovarian tumors can dictate eligibility for PARP inhibitor therapy.
Training and Certification
Pathologists specializing in gynecologic pathology typically complete a residency in anatomic pathology followed by a fellowship in gynecologic or surgical pathology. Certification is often obtained through national boards (e.g., the American Board of Pathology) and may involve subspecialty examinations.
Research and Emerging Trends
Current research focuses on integrating multi‑omics data, developing liquid biopsy approaches for early detection of gynecologic cancers, and refining risk stratification models based on histologic and molecular markers.
Related Fields
Gynecologic pathology overlaps with reproductive endocrinology, obstetrics, surgical oncology, and reproductive medicine, forming a multidisciplinary network aimed at improving women’s health outcomes.